The Centre for Addiction and Mental Health (CAMH) is increasingly becoming a destination of choice for some of the world's leading mental health researchers. Through the North Star Initiative, CAMH’s $10-million commitment to attract and support leading mental health and brain science researchers from around the world, and broader recruitment efforts, CAMH is contributing to Canada's "brain gain", strengthening both Toronto's position as a global research hub and CAMH’s leadership in mental health discovery.
Recent recruits include researchers from leading institutions across the US and the UK, each bringing expertise that spans neuroscience, psychiatry, brain imaging, and mental health research. Building on our recent feature of Drs. Fiona Coutts and Ariel Rokem, we're shining a spotlight on three additional researchers who have chosen CAMH as the place to advance their work and pursue ambitious science in an environment built to translate discovery into better mental health care.
Translating preclinical research into patient care
For Dr. Talia Lerner moving to CAMH gives her the opportunity to do what she has always wanted: to bridge the gap between preclinical and clinical research and maximising the impact of scientific discoveries on patient care.
As the second North Star recruit, Dr. Lerner joined CAMH from Northwestern University Feinberg School of Medicine, where she led pioneering work in understanding how individual differences in brain circuits can influence motivation, learning, and decision-making, and contribute to addiction, depression, Parkinson’s Disease and many other neuropsychiatric disorders.
In her new role as a Senior Scientist and Scientific Head of Pre-clinical Neuroscience within CAMH’s Neuroscience Institute, Dr. Lerner will lead early-stage research understanding why individuals differ in vulnerability to psychiatric disorders and how this information can be used to develop more precise, biologically-grounded psychiatric treatments, laying the foundation for the future of mental healthcare.
What motivated her move was CAMH's uniquely integrated research environment.
“I see so many fascinating discoveries about the brain, but too often they don’t end up having a meaningful impact on patient care. Being at CAMH, in this unique setting, in this new leadership role, gives me the opportunity I've always wanted to bridge the preclinical-clinical divide and maximize the impact our discoveries can have. With one of the largest mental health and addiction patient bases in the world, CAMH is uniquely positioned to help move preclinical research toward real-world applications,” says Dr. Lerner.
A similar passion for translating laboratory findings into patient care motivates Dr. Wei-li Chang. As a practicing psychiatrist and Scientist at the Brain Health Imaging Centre, her research is directly inspired by her experience working with patients.
“I became interested in studying how childhood adversity changes the brain after seeing how frequently this contributed to my patients’ mental health struggles, even decades later. I think of it as a loop, where my preclinical work is directly motivated by my experiences working with patients, and then I use these preclinical discoveries to improve the designs of clinical trials,” explains Dr. Chang.
Originally from Houston, Texas, Dr. Chang joined CAMH from Columbia University, where she completed her psychiatric residency training and postdoctoral research fellowship. CAMH's collaborative research environment, reputation in brain imaging, and strong connection of preclinical and clinical work were key factors in her decision to make Toronto her new home.
“CAMH stood out because of its robust clinical research programs and the many opportunities to broaden the impact of my work,” says Dr. Chang. “The Brain Health Imaging Centre is a world leader in brain imaging and has already built important bridges between preclinical and clinical research, making it an ideal fit for my work. Combined with CAMH's commitment to growing psychiatric neuroscience and investing in new research infrastructure through the Temerty Discovery Centre, it offers an exceptional environment to translate discoveries into meaningful impact.”
Advancing understanding of adult autism and neurodiversity
For Dr. John Strang, joining CAMH offers the opportunity to advance research that addresses some of the most pressing questions in adult autism care. A clinical neuropsychologist and Senior Scientist at the Azrieli Adult Neurodevelopmental Centre, Dr. Strang joins CAMH from Children's National Hospital and George Washington University in Washington, D.C., where he founded and directed the Gender and Autism Program. Throughout his career, his research has focused on populations often underrepresented in research and clinical care, including autistic adults, 2SLGBTQ+ communities, and people with intersex variations.
Dr. Strang was drawn to CAMH's unique integration of research, clinical care, and education, as well as the Azrieli Adult Neurodevelopmental Centre's internationally recognized expertise in autism and neurodevelopmental research. The opportunity to collaborate across disciplines, including neuroscience, brain imaging, genetics, health economics, health services and policy research, and implementation science, was another key factor in his decision to join CAMH.
A major focus of his work will be advancing understanding of late-diagnosed autism in adulthood, an area he describes as one of the most clinically pressing and complex questions in the field. His work aims to help examine how adults seeking autism assessments can be best supported, while developing new models of diagnosis and care in partnership with the autistic community.
“The Azrieli Centre is an ideal setting to advance clinical research in this area, including the development and testing of novel service pathways co-developed with the autistic community, making it a natural home for my work,” says Dr. Strang. “The ultimate goal of this work would be efficient models of diagnosis and support that autistic and neurodivergent people themselves embrace.”
Building the future of mental health research
Together, these researchers reflect the growing momentum behind CAMH's efforts to attract world-leading talent and accelerate discoveries that improve mental health care. Their decision to join CAMH highlights the strength of its integrated model, where research, clinical care, and education work hand in hand, and the opportunities created through major investments such as the Temerty Discovery Centre, set to open in late 2027. The new Centre will expand CAMH's capacity to accelerate scientific discovery and translate breakthroughs into better treatments, better care and improved outcomes for people living with mental illness and addiction – in Toronto, across Ontario, and throughout Canada.